Team:Yale/MaterialsMethods
From 2014.igem.org
(Difference between revisions)
(41 intermediate revisions not shown) | |||
Line 125: | Line 125: | ||
<td colspan="12"> | <td colspan="12"> | ||
- | <h1 style="margin-top:15px; margin-bottom:25px; font-size:35px;text-align:center"> | + | <h1 style="margin-top:15px; margin-bottom:25px; font-size:35px;text-align:center">T7 Riboregulation System</h1> |
<div class = "well"> | <div class = "well"> | ||
<p> | <p> | ||
- | + | <ol type="I"><li><strong>Strains, Plasmids, and Reagents</strong><ul style="list-style-type:square"> | |
</p> | </p> | ||
<p> | <p> | ||
- | <em>E. coli </em> | + | <li><em>E. coli </em> |
strains used in this study included BL21(<em>E. coli</em> B F- <em>dcm ompT hsdS</em>(r<sub>B</sub>- m<sub>B</sub>-) gal [malB<sup>+</sup>]<sub>K-12</sub> | strains used in this study included BL21(<em>E. coli</em> B F- <em>dcm ompT hsdS</em>(r<sub>B</sub>- m<sub>B</sub>-) gal [malB<sup>+</sup>]<sub>K-12</sub> | ||
(λ<sup>S</sup>)), BL21(DE3)( F<sup>–</sup> ompT gal dcm lon hsdS<sub>B</sub>(r<sub>B</sub><sup>-</sup> m<sub>B</sub><sup>-</sup>) λ(DE3 [lacI lacUV5-T7 | (λ<sup>S</sup>)), BL21(DE3)( F<sup>–</sup> ompT gal dcm lon hsdS<sub>B</sub>(r<sub>B</sub><sup>-</sup> m<sub>B</sub><sup>-</sup>) λ(DE3 [lacI lacUV5-T7 | ||
Line 138: | Line 138: | ||
spectinomycin (Sigma-Aldrich). Kanamycin and spectinomycin were used at 30 mg/mL and 95 mg/mL respectively. | spectinomycin (Sigma-Aldrich). Kanamycin and spectinomycin were used at 30 mg/mL and 95 mg/mL respectively. | ||
</p> | </p> | ||
- | < | + | <li> |
One percent agarose gels were made with 0.5% TBE obtained from American Bio and stained with either ethidium bromide (Sigma-Aldrich) (screening) or SYBR | One percent agarose gels were made with 0.5% TBE obtained from American Bio and stained with either ethidium bromide (Sigma-Aldrich) (screening) or SYBR | ||
Safe (Invitrogen) (cloning) in the case of cloning. Gel extraction and purification was completed with QIAprep Gel Extraction Kit following the protocol | Safe (Invitrogen) (cloning) in the case of cloning. Gel extraction and purification was completed with QIAprep Gel Extraction Kit following the protocol | ||
Line 146: | Line 146: | ||
restriction enzymes, and Gibson Assembly Master Mix are from New England Biolabs. Hifi HotStart Readymix and 2GFAST Readymix with loading dye for PCR were | restriction enzymes, and Gibson Assembly Master Mix are from New England Biolabs. Hifi HotStart Readymix and 2GFAST Readymix with loading dye for PCR were | ||
obtained from KAPA Biosystems. | obtained from KAPA Biosystems. | ||
+ | </p></ul> | ||
+ | <p><li> <strong>Plasmids</strong> | ||
</p> | </p> | ||
- | < | + | <ul><li> |
- | + | ||
- | + | ||
- | + | ||
Plasmid pZE21_Y12_a12C_c contains a ColE1 origin of replication and a kanamycin resistance marker. At the multiple cloning site in the reverse direction is | Plasmid pZE21_Y12_a12C_c contains a ColE1 origin of replication and a kanamycin resistance marker. At the multiple cloning site in the reverse direction is | ||
inserted a trans-activating RNA (taRNA) sequence expressed by P<sub>LtetO</sub> promoter and in the forward direction is a chloramphenicol resistance | inserted a trans-activating RNA (taRNA) sequence expressed by P<sub>LtetO</sub> promoter and in the forward direction is a chloramphenicol resistance | ||
Line 157: | Line 156: | ||
pZA21_tRNA_TAGG has a p15a origin of replication and a spectinomycin resistance marker. In its multiple cloning site it contains a 3 Tyrosine ELP | pZA21_tRNA_TAGG has a p15a origin of replication and a spectinomycin resistance marker. In its multiple cloning site it contains a 3 Tyrosine ELP | ||
purification tag adjacent to GFP. The recombinant protein expression is driven by P<sub>LtetO</sub>. | purification tag adjacent to GFP. The recombinant protein expression is driven by P<sub>LtetO</sub>. | ||
- | </p> | + | </p></ul> |
<p> | <p> | ||
- | < | + | <li><strong>Gibson Assembly of plasmids from PCR products</strong> |
</p> | </p> | ||
- | < | + | <ul><li> |
Fragments were assembled into plasmids using Gibson Assembly (Gibson, Young et al. 2009). Gel purified PCR products with 5’ complimentary overhangs were | Fragments were assembled into plasmids using Gibson Assembly (Gibson, Young et al. 2009). Gel purified PCR products with 5’ complimentary overhangs were | ||
combined in equimolar ratios with ten microliters of Gibson Assembly Master Mix and additional nuclease free water to obtain a reaction volume of twenty | combined in equimolar ratios with ten microliters of Gibson Assembly Master Mix and additional nuclease free water to obtain a reaction volume of twenty | ||
microliters. The reaction was carried out in a thermocycler held constant at 50°C over the course of one hour. | microliters. The reaction was carried out in a thermocycler held constant at 50°C over the course of one hour. | ||
- | </p> | + | </p></ul> |
<p> | <p> | ||
- | < | + | <li><strong>Transformation of Plasmids through Electroporation</strong> |
</p> | </p> | ||
- | < | + | <ul><li> |
Transformation was carried out through electroporation. First, the plasmid to be transformed was desalted for an hour using a Millipore (type VSWP) drop | Transformation was carried out through electroporation. First, the plasmid to be transformed was desalted for an hour using a Millipore (type VSWP) drop | ||
dialysis film with 0.025 μm on ultra-pure Milli-Q water. One mL of liquid culture was centrifuged and washed twice with Milli-Q water. After washing, the | dialysis film with 0.025 μm on ultra-pure Milli-Q water. One mL of liquid culture was centrifuged and washed twice with Milli-Q water. After washing, the | ||
Line 177: | Line 176: | ||
immediately transferred to 1 mL of LB Lennox and placed in a 37° incubator to recover for an hour. The cells were then plated on LB Lennox agar with an | immediately transferred to 1 mL of LB Lennox and placed in a 37° incubator to recover for an hour. The cells were then plated on LB Lennox agar with an | ||
antibiotic selection factor for the transformed plasmid vector. | antibiotic selection factor for the transformed plasmid vector. | ||
- | </p> | + | </p></ul> |
- | + | ||
- | + | ||
- | </ | + | |
<p> | <p> | ||
+ | <li><strong>Assembly of T7 RNA Polymerase in pZE21_Y12_a12C backbone</strong> | ||
+ | </p><ul> | ||
+ | <li> | ||
The plasmid pZE21_Y12_a12C_T7RNAPol was Gibson Assembled from the T7 RNA Polymerase gene obtained from BL21(DE3) and the pZE_Y12_a12C backbone. The T7 RNA | The plasmid pZE21_Y12_a12C_T7RNAPol was Gibson Assembled from the T7 RNA Polymerase gene obtained from BL21(DE3) and the pZE_Y12_a12C backbone. The T7 RNA | ||
Polymerase gene was obtained from BL21(DE3) through colony PCR with primers pZE21_T7_F and pZE21_T7_R that anneal at either end of the T7 RNA Polymerase | Polymerase gene was obtained from BL21(DE3) through colony PCR with primers pZE21_T7_F and pZE21_T7_R that anneal at either end of the T7 RNA Polymerase | ||
Line 189: | Line 188: | ||
fragment was run on a 2% agarose gel stained with SYBR Safe, excised, and gel purified. | fragment was run on a 2% agarose gel stained with SYBR Safe, excised, and gel purified. | ||
</p> | </p> | ||
- | < | + | <li> |
pZE_Y12_a12C was obtained as a plasmid, transformed into Mach1 cells for cloning, and purified from liquid culture via mini-prep. The plasmid backbone was | pZE_Y12_a12C was obtained as a plasmid, transformed into Mach1 cells for cloning, and purified from liquid culture via mini-prep. The plasmid backbone was | ||
amplified with primers pZgib-F and a12gib-r. The reaction was carried out in Kapa Hifi Hotsart Readymix following the Kapa Biosystems protocol. The | amplified with primers pZgib-F and a12gib-r. The reaction was carried out in Kapa Hifi Hotsart Readymix following the Kapa Biosystems protocol. The | ||
Line 198: | Line 197: | ||
PCR Purification Kit to yield a linear fragment of the desired backbone vector. | PCR Purification Kit to yield a linear fragment of the desired backbone vector. | ||
</p> | </p> | ||
- | < | + | <li> |
Concentration of the DNA was obtained using the plate reader. The two fragments were assembled with New England Biolabs 2X Gibson Assembly Master Mix | Concentration of the DNA was obtained using the plate reader. The two fragments were assembled with New England Biolabs 2X Gibson Assembly Master Mix | ||
following the NEB Protocol. The resulting plasmid was drop dialyzed for one hour using Millipore drop dialysis filter paper and Milli-Q water. One μL of | following the NEB Protocol. The resulting plasmid was drop dialyzed for one hour using Millipore drop dialysis filter paper and Milli-Q water. One μL of | ||
Line 204: | Line 203: | ||
and allowed to grow overnight in a 37°C incubator. | and allowed to grow overnight in a 37°C incubator. | ||
</p> | </p> | ||
- | < | + | <li> |
A dozen colonies were selected for screening. The initial screening with colony PCR was completed with primers pz-integration-f and pz-integration-r and | A dozen colonies were selected for screening. The initial screening with colony PCR was completed with primers pz-integration-f and pz-integration-r and | ||
K2G FAST Readymix with loading dye following the protocol from Kapa Biosystems. The annealing temperature for the reaction was 58°C and the annealing time | K2G FAST Readymix with loading dye following the protocol from Kapa Biosystems. The annealing temperature for the reaction was 58°C and the annealing time | ||
Line 210: | Line 209: | ||
bromide for 30 minutes at 140V. The gel was imaged on a Bio-Rad Molecular Imager Gel Doc XR+. | bromide for 30 minutes at 140V. The gel was imaged on a Bio-Rad Molecular Imager Gel Doc XR+. | ||
</p> | </p> | ||
- | < | + | <li> |
A second screening assay was carried out with restriction enzymes KpnI and HindIII in the single and double digest method following the protocols specified | A second screening assay was carried out with restriction enzymes KpnI and HindIII in the single and double digest method following the protocols specified | ||
by New England Biolabs. Five clones were grown up in 2XYT media with kanamycin overnight in a 37°C incubator and mini-prepped the following day. Three | by New England Biolabs. Five clones were grown up in 2XYT media with kanamycin overnight in a 37°C incubator and mini-prepped the following day. Three | ||
Line 217: | Line 216: | ||
taRNA, crRNA, multiple cloning site, and terminator was amplified from purified plasmids using pz-integration-f and pz-integration-r with Hifi Hotstart | taRNA, crRNA, multiple cloning site, and terminator was amplified from purified plasmids using pz-integration-f and pz-integration-r with Hifi Hotstart | ||
Readymix for sequencing. Sequencing was completed by Keck DNA Sequencing Facility. The alignment was analyzed using Geneious. | Readymix for sequencing. Sequencing was completed by Keck DNA Sequencing Facility. The alignment was analyzed using Geneious. | ||
+ | </p></ul> | ||
+ | <li> | ||
+ | <strong>Assembly of T7 Phage Promoter-super-folder GFP in pZA21 backbone</strong> | ||
</p> | </p> | ||
- | < | + | <ul><li> |
- | + | ||
- | + | ||
- | + | ||
The plasmid pZA21_T7_sfGFP was assembled from a linear fragment of sfGFP with a RBS and T7 promoter attached to the 5’ untranslated region (UTR) amplified | The plasmid pZA21_T7_sfGFP was assembled from a linear fragment of sfGFP with a RBS and T7 promoter attached to the 5’ untranslated region (UTR) amplified | ||
from plasmid pZE21::sfGFP and the pZA21 backbone amplified from pZA21_tRNA_TAGG. The linear fragment of T7_RBS_sfGFP was PCR amplified from pZE21::sfGFP | from plasmid pZE21::sfGFP and the pZA21 backbone amplified from pZA21_tRNA_TAGG. The linear fragment of T7_RBS_sfGFP was PCR amplified from pZE21::sfGFP | ||
Line 230: | Line 229: | ||
plasmid was dubbed pZE21::T7sfGFP. | plasmid was dubbed pZE21::T7sfGFP. | ||
</p> | </p> | ||
- | < | + | <li> |
Screening for the replacement of the original P<sub>LtetO</sub> promoter was verified by sequencing. Sequencing primers for the pZE backbone | Screening for the replacement of the original P<sub>LtetO</sub> promoter was verified by sequencing. Sequencing primers for the pZE backbone | ||
pz-integration-f and pz-integration-r were used with Hifi Hotstart Readymix with the NEB protocol to amplify the multiple cloning site of the pZE21 | pz-integration-f and pz-integration-r were used with Hifi Hotstart Readymix with the NEB protocol to amplify the multiple cloning site of the pZE21 | ||
Line 236: | Line 235: | ||
analyzed using Geneious. | analyzed using Geneious. | ||
</p> | </p> | ||
- | < | + | <li> |
The pZA21 backbone was amplified with primers T7sfGFP_pZA21_F and T7sfGFP_pZA21_R and Hifi Hotstart Readymix with the NEB protocol. The reaction was | The pZA21 backbone was amplified with primers T7sfGFP_pZA21_F and T7sfGFP_pZA21_R and Hifi Hotstart Readymix with the NEB protocol. The reaction was | ||
carried out with an annealing temperature of 56°C and an extension time of 00:03:00. The product was treated with Dpn1 to eliminate remaining template DNA. | carried out with an annealing temperature of 56°C and an extension time of 00:03:00. The product was treated with Dpn1 to eliminate remaining template DNA. | ||
Line 243: | Line 242: | ||
fragment was PCR purified. | fragment was PCR purified. | ||
</p> | </p> | ||
- | < | + | <li> |
A linear fragment of T7_sfGFP was amplified with overhangs to pZA21 containing the restriction sites AatII and BamHI-HF. T7_sfGFP was amplified from | A linear fragment of T7_sfGFP was amplified with overhangs to pZA21 containing the restriction sites AatII and BamHI-HF. T7_sfGFP was amplified from | ||
pZE21::T7sfGFP previously constructed using primers pZE21_T7sfGFP_AatII_F and pZA21_T7sfGFP_BamHI_R and Hifi Hotstart Readymix with the NEB protocol. The | pZE21::T7sfGFP previously constructed using primers pZE21_T7sfGFP_AatII_F and pZA21_T7sfGFP_BamHI_R and Hifi Hotstart Readymix with the NEB protocol. The | ||
Line 251: | Line 250: | ||
restriction enzymes AatII and BamHI-HF. The resulting fragment was PCR purified. | restriction enzymes AatII and BamHI-HF. The resulting fragment was PCR purified. | ||
</p> | </p> | ||
- | < | + | <li> |
A ligation reaction using T4 DNA ligase from NEB was conducted with the fragment of PZA21 backbone and T7sfGFP following the NEB protocol. Following the | A ligation reaction using T4 DNA ligase from NEB was conducted with the fragment of PZA21 backbone and T7sfGFP following the NEB protocol. Following the | ||
ligation, 5 μL of the reaction mixture was transformed into Mach1 cells. The colonies were picked the next day and grown up overnight. Liquid culture were | ligation, 5 μL of the reaction mixture was transformed into Mach1 cells. The colonies were picked the next day and grown up overnight. Liquid culture were | ||
Line 265: | Line 264: | ||
<td colspan="12" > | <td colspan="12" > | ||
- | <h1 style="margin-top:15px; margin-bottom:25px; font-size:35px;text-align:center;"> | + | <h1 style="margin-top:15px; margin-bottom:25px; font-size:35px;text-align:center;">Anti-Microbial Peptide Construct</h1> |
<div class = "well"> | <div class = "well"> | ||
- | < | + | <ol type="I"><li><strong>Strains, Plasmids, and Reagents</strong><ul style="list-style-type:square"> |
- | The construct sequence was synthesized by Genscript and shipped as pUC57-Kan_2StrepFLAGLLFP151GFP, and transplanted to the pZE21 plasmid, pZE21_2StrepFLAGLLFP151GFP (BBa_K1396000). | + | <li><strong>Construct Synthesis and Expression: Strains, Plasmids, and Reagents</strong> <br /> |
- | + | <ul><li>The construct sequence was synthesized by Genscript and shipped as pUC57-Kan_2StrepFLAGLLFP151GFP, and transplanted to the pZE21 plasmid, pZE21_2StrepFLAGLLFP151GFP (BBa_K1396000). | |
+ | |||
All plasmids were first grown in Mach1, then purified and retransformed into C31POE.ompT.lon.endA.ΔtolC, a recoded strain with all amber stop codons (TAG) replaced, and Release Factor 1 replaced with Streptomycin resistance. It is thus able to encode nonstandard amino acids such as L-DOPA, the incorporation of which is facilitated by the DOPA orthogonal translation system (OTS). | All plasmids were first grown in Mach1, then purified and retransformed into C31POE.ompT.lon.endA.ΔtolC, a recoded strain with all amber stop codons (TAG) replaced, and Release Factor 1 replaced with Streptomycin resistance. It is thus able to encode nonstandard amino acids such as L-DOPA, the incorporation of which is facilitated by the DOPA orthogonal translation system (OTS). | ||
<br /> | <br /> | ||
- | A second strain was made with the Tyrosine suppressor system transformed instead, so the construct can be expressed with tyrosines in the place of L-DOPA, as L-DOPA is very toxic to cells. The construct was then separated into smaller constructs such as pZE21_LLFP151 (BBa_K1396001), pZE21_FP151GFP (BBa_K1396002), pZE21_FP151 (BBa_K1396003). | + | <li>A second strain was made with the Tyrosine suppressor system transformed instead, so the construct can be expressed with tyrosines in the place of L-DOPA, as L-DOPA is very toxic to cells. The construct was then separated into smaller constructs such as pZE21_LLFP151 (BBa_K1396001), pZE21_FP151GFP (BBa_K1396002), pZE21_FP151 (BBa_K1396003). |
</p> | </p> | ||
+ | </ul> | ||
+ | <li> | ||
+ | <strong> We hypothesize that we can develop an improved version of the current adhesives by developing a fusion protein of Mgfp-5 with Mefp-1 as the anchoring region for the anti-biofouling peptide. </strong> An integral part of developing this peptide is to co-translationally insert L-DOPA into our peptide, which has never been done before with mussel foot proteins (Figure 1). In this process of orthogonal translation, we first will get rid of the UAG stop codon and then transform the strain to synthesize tRNA and tRNA transferase that corresponds to the UAG codon and the L-DOPA non-standard amino acid to develop the genetically recoded organism (GRO). The advantage of this procedure is that we have the ability to skip the time-consuming and inefficient tyrosinase enzyme treatment step. | ||
+ | </p><br> | ||
+ | |||
+ | <center><img src = "https://static.igem.org/mediawiki/2014/b/bd/Dopaintegration.jpg" width = "500" height = "auto"></img><br /> | ||
+ | <i><strong>Figure 1. </strong>Integration of L-DOPA into peptide through orthogonal translation.</i></center> | ||
+ | |||
+ | <p style = "padding-top:20px;"> | ||
+ | <li><strong>Protein Purification</strong> | ||
+ | We plan to purify the protein by using the Twin Strep Tag in tandem with the FLAG tag, which was included in our master construct of the anti-biofouling peptide (Figure 2). | ||
+ | </p><br> | ||
+ | |||
+ | <center><img src ="https://static.igem.org/mediawiki/2014/3/39/IGEM_construct_Design_wiki.png" width = "600" height = "auto"></img> <br /> | ||
+ | <i><strong>Figure 2. </strong>A diagram illustrating the components in our final construct. The Twin Strep and FLAG tags are indicated.</i></center><br> | ||
<p> | <p> | ||
- | + | <ul><li>The FLAG tag is perfectly cleavable by the enzyme enterokinase. The FLAG tag is made up of 8 amino acids and works well for low-abundance proteins. It is hydrophilic, so it will most likely not interfere with protein folding and function of the target protein. The Strep tag is also made up of 8 amino acids that will not disturb the protein’s functions. We chose the FLAG tag because it is perfectly cleavable. The protein will be purified in a Strep-Tactin<sup>R</sup> Sepharose<sup>R</sup> column. In order to address the adhesive L-DOPA component, our final step is to elute with a base to reduce the amount of the anti-biofouling peptide that sticks to the column due to L-DOPA adhesion (Figure 3).</p> | |
- | + | ||
+ | |||
<p> | <p> | ||
- | |||
- | |||
- | |||
Flag Tag Sequence: Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys <br /> | Flag Tag Sequence: Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys <br /> | ||
Strep Tag Sequence: Sequence: Trp-Ser-His-Pro-Gln-Phe-Glu-Lys | Strep Tag Sequence: Sequence: Trp-Ser-His-Pro-Gln-Phe-Glu-Lys | ||
- | </p> | + | </p> <br> |
+ | |||
+ | <center><img src ="https://static.igem.org/mediawiki/2014/3/33/Purification2014.png" height = "500" width = "auto"></img><br><br/><i><strong>Figure 3. </strong>A diagram illustrating the proposed purification method.</i></center> | ||
+ | |||
</div> | </div> | ||
</td> | </td> | ||
Line 298: | Line 314: | ||
<div class = "well"> | <div class = "well"> | ||
<p> | <p> | ||
- | <ul><li><strong><u>Adhesion:</u></strong> <ul><li><strong> Subject peptide coated surfaces to liquid erosion: </strong><ul><li>A number of ASTM assays used in industrial coating testing were investigated, but none offered the level of quantitation desired for our applications. Therefore, an original rig was designed and built to introduce liquid based erosion by laminar flow through a bath. This system directly mimics the drag that a coated surface might experience on a ship's hull. Precise specifications of the rig are provided in a separate section below.</ul><br> | + | <ol type="I"><li><strong>Strains, Plasmids, and Reagents</strong><ul style="list-style-type:square"> |
+ | <li><strong><u>Adhesion:</u></strong> <ul><li><strong> Subject peptide coated surfaces to liquid erosion: </strong><ul><li>A number of ASTM assays used in industrial coating testing were investigated, but none offered the level of quantitation desired for our applications. Therefore, an original rig was designed and built to introduce liquid based erosion by laminar flow through a bath. This system directly mimics the drag that a coated surface might experience on a ship's hull. Precise specifications of the rig are provided in a separate section below.</ul><br> | ||
<center><img src="https://static.igem.org/mediawiki/2014/thumb/d/d5/Erosion_Rig_Image.png/800px-Erosion_Rig_Image.png"></center> | <center><img src="https://static.igem.org/mediawiki/2014/thumb/d/d5/Erosion_Rig_Image.png/800px-Erosion_Rig_Image.png"></center> | ||
<p> | <p> | ||
<center> | <center> | ||
- | <i><strong>Figure | + | <i><strong>Figure 4.</strong> A diagram illustrating the configuration of the erosion rig developed to introduce coated surfaces to liquid erosion.</i> |
</center> | </center> | ||
</p><br> | </p><br> | ||
Line 322: | Line 339: | ||
<p> | <p> | ||
<center> | <center> | ||
- | <i><strong>Figure | + | <i><strong>Figure 5.</strong> This is an AFM cantilever with a 20 µm silica bead fixed to the tip. By functionalizing the tip, we can control the adhesion interface for which we test our MAP adhesives. In this case, we intend to use a silica bead to measure the adhesion of our coating to a silica interface. This measurement was conducted with the assistance of Dr. Michael Rooks at the Yale Institute for Nanoscience and Quantum Engineering.</i></center><p><br> |
Line 330: | Line 347: | ||
<p> | <p> | ||
<center> | <center> | ||
- | <i><strong>Figure | + | <i><strong>Figure 6.</strong> This diagram illustrates how a DNA handle can be linked to a protein of interest to bind the protein to an optical tweezer bead into which the high intensity laser can be fired to engender a pull force. We intend to conduct a similar protocol with our adhesive peptide.<sup>23</sup> This measurement was conducted with the assistance of Dr. Junyi Jiao in the lab of Dr. Yongli Zhang from the Yale Department of Cell Biology.</i> |
</center> | </center> | ||
- | </p> | + | </p></ul> |
+ | <li><strong>Preparation of Cell-Tak<sup>TM</sup> films</strong><ul><li> | ||
+ | Cell-Tak<sup>TM</sup> is a mixture of mussel foot proteins 1 and 2 in an approximate 75% to 25% ratio, respectively. The protocol used to deposit Cell-Tak<sup>TM</sup>relies upon the property of L-DOPA to come out of solution when the pH is increased. Cell-Tak<sup>TM</sup> is constituted in 5% acetic acid. To prepare a film, 10 µL of a 2.36 mg/mL Cell-Tak<sup>TM</sup> solution was spotted onto the substrate. To trigger binding, 10 µL of 0.2 M sodium bicarbonate was added to increase the pH to ~8-9. Films were then allowed to dry for 30 min at 37ºC and then washed with DI water. Prepared films were stored in an incubator until ready for use. | ||
+ | <li>Spin coating was investigated as a new modality for depositing a protein monolayer. However, the hydrophobicity of the protein did not allow for adequate wetting of the substrates by Cell-Tak<sup>TM</sup> for proper spin coating. In addition, a method used for hydrogel preparation involving incubation of a coverslip in Rain-X was tested to deposit protein layers. A coverslip was coated in Cell-Tak<sup>TM</sup> and then covered by the super hydrophobic Rain-X coated coverslip. The coverslips were then pulled apart and the protein coated surface was allowed to dry. However, the consistency in thickness desired for our application made the precipitation preparation the method we chose as our standard. | ||
</div> | </div> | ||
Latest revision as of 03:37, 18 October 2014
Materials and Methods |
|||||||||||
T7 Riboregulation System
| |||||||||||
Anti-Microbial Peptide Construct
|
|||||||||||
Methods for Assaying Coating Adhesion Properties |
|||||||||||
|